Scoring Patients’ Risk in Differentiated Thyroid Cancer

Publisher： Karger

E-ISSN： 2296-5262|24|6|561-568

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.24, Iss.6, 2002-01, pp. : 561-568

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative 131I dose over 37 GBq

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 1, 2015-07 ,pp. : 117-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer

By  

CLINICAL ENDOCRINOLOGY, Vol. 88, Iss. 2, 2018-02 ,pp. : 303-310

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical applications of SPECT/CT after first I‐131 ablation in patients with differentiated thyroid cancer

By  

CLINICAL ENDOCRINOLOGY, Vol. 81, Iss. 3, 2014-09 ,pp. : 445-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidental nodal metastasis of differentiated thyroid carcinoma in neck dissection specimens from head and neck cancer patients

By  

Journal of Laryngology and Otology, Vol. 131, Iss. 4, 2017-02 ,pp. : 368-371

Cambridge University Press

Access to resources Recommend Favorite

Prophylactic central neck dissection in 68 patients with lateral compartment metastases from well‐differentiated thyroid cancer

By  

CLINICAL OTOLARYNGOLOGY, Vol. 43, Iss. 1, 2018-02 ,pp. : 365-369

John Wiley & Sons Inc

Access to resources Recommend Favorite